| Optogenetic control of chemokine receptor signal and T-cell migration Y Xu, YM Hyun, K Lim, H Lee, RJ Cummings, SA Gerber, S Bae, TY Cho, ... Proceedings of the National Academy of Sciences 111 (17), 6371-6376, 2014 | 128 | 2014 |
| Protective effects of chlorogenic acid on acute hepatotoxicity induced by lipopolysaccharide in mice Y Xu, J Chen, X Yu, W Tao, F Jiang, Z Yin, C Liu Inflammation Research 59, 871-877, 2010 | 128 | 2010 |
| Dendritic Cell‐Specific Transmembrane Protein (DC‐STAMP) Regulates Osteoclast Differentiation via the Ca2+/NFATc1 Axis YH Chiu, E Schwarz, D Li, Y Xu, TR Sheu, J Li, KL de Mesy Bentley, ... Journal of cellular physiology 232 (9), 2538-2549, 2017 | 38 | 2017 |
| Engineering and functionalization of large circular tandem repeat protein nanoparticles CE Correnti, JP Hallinan, LA Doyle, RO Ruff, CA Jaeger-Ruckstuhl, Y Xu, ... Nature Structural & Molecular Biology, 1-9, 2020 | 32 | 2020 |
| Preclinical development of T-cell receptor-engineered T-cell therapy targeting the 5T4 tumor antigen on renal cell carcinoma Y Xu, AJ Morales, MJ Cargill, AMH Towlerton, DG Coffey, EH Warren, ... Cancer Immunology, Immunotherapy 68, 1979-1993, 2019 | 20 | 2019 |
| Current status of antigen-specific T-cell immunotherapy for advanced renal-cell carcinoma Y Xu, CP Miller, EH Warren, SS Tykodi Human Vaccines & Immunotherapeutics 17 (7), 1882-1896, 2021 | 11 | 2021 |
| Ultradeep, targeted sequencing reveals distinct mutations in blood compared to matched bone marrow among patients with multiple myeloma DG Coffey, QV Wu, AMH Towlerton, S Ornelas, AJ Morales, Y Xu, ... Blood Cancer Journal 9 (10), 77, 2019 | 11 | 2019 |
| CD4 and CD8 co-receptors modulate functional avidity of CD1b-restricted T cells CA James, Y Xu, MS Aguilar, L Jing, ED Layton, M Gilleron, AJ Minnaard, ... Nature Communications 13 (1), 78, 2022 | 10 | 2022 |
| Toll-like receptor 4 agonist injection with concurrent radiotherapy in patients with metastatic soft tissue sarcoma: A phase 1 nonrandomized controlled trial YD Seo, H Lu, G Black, K Smythe, Y Yu, C Hsu, J Ng, PH De Viveiros, ... JAMA oncology 9 (12), 1660-1668, 2023 | 9 | 2023 |
| Immunophenotypic correlates of sustained MRD negativity in patients with multiple myeloma DG Coffey, F Maura, E Gonzalez-Kozlova, JJ Diaz-Mejia, P Luo, Y Zhang, ... Nature communications 14 (1), 5335, 2023 | 6 | 2023 |
| Normalization of the immune microenvironment during lenalidomide maintenance is associated with sustained MRD negativity in patients with multiple myeloma DG Coffey, F Maura, E Gonzalez-Kozlova, J Diaz-Mejia, P Luo, Y Zhang, ... Blood 138, 329, 2021 | 6 | 2021 |
| Effect of intratumoral (IT) injection of the toll-like receptor 4 (TLR4) agonist G100 on a clinical response and CD4 T-cell response locally and systemically. YD Seo, J Zhou, K Morse, J Patino, S Mackay, EY Kim, EU Conrad, ... Journal of Clinical Oncology 36 (5_suppl), 71-71, 2018 | 4 | 2018 |
| Therapeutic targeting of tumor spheroids in a 3D microphysiological renal cell carcinoma-on-a-chip system CP Miller, M Fung, CA Jaeger-Ruckstuhl, Y Xu, EH Warren, S Akilesh, ... Neoplasia 46, 100948, 2023 | 2 | 2023 |
| Single cell atlas of kidney cancer endothelial cells reveals distinct expression profiles and phenotypes Y Xu, CP Miller, J Xue, Y Zheng, EH Warren, SS Tykodi, S Akilesh BJC Reports 2 (1), 23, 2024 | 1 | 2024 |
| Immunohistochemical detection of 5T4 in renal cell carcinoma CP Miller, F Shokri, S Akilesh, Y Xu, EH Warren, SS Tykodi, M Tretiakova Applied Immunohistochemistry & Molecular Morphology 31 (3), 135-144, 2023 | 1 | 2023 |
| Integrated TCR repertoire analysis and single-cell transcriptomic profiling of tumor-infiltrating T cells in renal cell carcinoma identifies shared and tumor-restricted … Y Xu, AJ Morales, AMH Towlerton, S Akilesh, CP Miller, SS Tykodi, ... Frontiers in Oncology 12, 952252, 2022 | 1 | 2022 |
| Signaling crosstalk between tumor endothelial cells and immune cells in the microenvironment of solid tumors Y Xu, CP Miller, SS Tykodi, S Akilesh, E Warren Frontiers in Cell and Developmental Biology 12, 1387198, 2024 | | 2024 |
| Case report: A persistently expanded T cell response in an exceptional responder to radiation and atezolizumab for metastatic non-small cell lung cancer DG Coffey, Y Xu, AMH Towlerton, M Kowanetz, P Hegde, M Darwish, ... Frontiers in Immunology 13, 961105, 2022 | | 2022 |
| Binding proteins specific for 5t4 and uses thereof SS Tykodi, XU Yuexin, EH Warren US Patent App. 16/768,617, 2022 | | 2022 |
| Intratumoral Injection of the Toll-like Receptor 4 Agonist G100 Induces Durable Local Control and Causes Immune Activation in the Tumor Microenvironment in Metastatic Soft … YD Seo, H Lu, G Black, K Smythe, C Hsu, Y Xu, E Warren, J Ng, E Conrad, ... ANNALS OF SURGICAL ONCOLOGY 29 (SUPPL 2), 360-360, 2022 | | 2022 |
